No specific risk factors for clots with AstraZeneca Covid-19 jab: Europe health regulator, SE Asia News & Top Stories

SINGAPORE (BLOOMBERG, REUTERS, AGENCE FRANCE-PRESSE) – The AstraZeneca Covid-19 vaccine came under the spotlight following reports of rare blood clots, some of them fatal, among some adult vaccine recipients.

Concerns about the vaccine centred on an unusual type of blood clot in the brain called cerebral venous sinus thrombosis (CVST).…

This data comes from the media intelligence and smart news insights monitoring platform.

Visit the original:

Comments are closed.